Watt Fun!

Her doctoral advisor told her to amuse herself, and Fiona Watt has done just that—probing individual stem cells and determining the genes and molecules that direct them to differentiate or cause them to contribute to cancer.

Written byKaren Hopkin
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Fiona Watt: Deputy Director, Wellcome Trust Centre for Stem Cell Research; Herchel Smith Professor of Molecular Genetics, University of Cambridge; Deputy Director, Cancer Research UK, Cambridge Research Institute. ALEX RUMFORD

Fiona Watt finished her thesis research in record time. It was the late 1970s, and Watt had joined the lab of Henry Harris at Oxford University. Harris had perfected a method for fusing normal cells with cancer cells, an approach that allowed him to look for molecules that prevented the abnormal growth of the resulting hybrid. “When I first went to see Professor Harris, he told me, ‘There are only two intellectually important problems: cancer and differentiation,’” says Watt. “Of course, I agreed—and still do! Then he asked, ‘Which do you want to work on?’ I said, ‘Differentiation.’ So he gave me cancer.”

At the time, Harris had compiled a list of potential molecular markers for cancer cells. His students were working their way down ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies